2016 ACR/ARHP Annual Meeting Archives - Page 148 of 219

Abstract Number: 1520

RA Flare after Total Hip and Total Knee Arthroplasty: Preliminary Outcomes at 1 Year
Abstract Number: 2238

RA Medication Preferences Among U.S. Patients in an Online Rheumatoid Arthritis Community
Abstract Number: 3120

RA Net: A Systems Biology Approach to Identify Genes Regulating Pathogenic Pathways in Rheumatoid Arthritis (RA) Fibroblast-like Synoviocytes (FLS)
Abstract Number: 3110

Rab4A Is Required for Development of Tregs, Restricts Antiphospholipid Antibody Production and Pro-Inflammatory Expansion of Macrophages and Neutrophils, and Blocks Pristane-Induced Intra-Alveolar Hemorrhage in a Mouse Model of SLE
Abstract Number: 2351

Racial Differences in Magnetic Resonance Image-Based Three-Dimensional Bone Shape of the Knee: Data from the Osteoarthritis Initiative (OAI)
Abstract Number: 116

Racial Differences in Self-Reported Pain and Disability: A Longitudinal Study of Knee Osteoarthritis
Abstract Number: 2501

Radiographic Damage in Patients with RA Increases By 8.3% per Year Disease Duration, in the Era of Biologic Dmards. Results from the Scqm Cohort
Abstract Number: 154

Radiographic Knee Osteoarthritis in Patients Complaining of Knee Pain: Ultrasound Features
Abstract Number: 2350

Radiographic Outcomes from a Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study of a Novel, Intra-Articular, Injectable, Wnt Inhibitor (SM04690) in the Treatment of Osteoarthritis of the Knee
Abstract Number: 716

Radiographic Progression and Changes in Inflammation and Structural Damage on Serial MRI Examinations over 5 Years in Patients with Ankylosing Spondylitis Treated with TNF-Alpha Inhibitors
Abstract Number: 588

Radiographic Progression Is Less Significant in Anti-Carbamylated Antibody-Positive Patients with Rheumatoid Arthritis (RA) Who Were Clinically Active and Under the Treatment with Biological Dmards
Abstract Number: 718

Radiographic Progression of Hip Arthritis in Patients with Ankylosing Spondylitis Treated with TNF Inhibitors
Abstract Number: 2534

Radiographic Remission in Patients with Seropositive RA at Ten Years after Diagnosis, Treated in a Real Life Setting
Abstract Number: 2353

Radiographic Variations in Hip Morphology Are Associated with Hip Symptoms: A Cross-Sectional Analysis of a Large Community-Based Cohort
Abstract Number: 428

Random Forest Models Using Electronic Health Record Data Are Predictive of One-Year Outcomes in Lupus Nephritis Patients Taking Mycophenolate Mofetil Induction Therapy
Abstract Number: 797

Randomized Clinical Trials of Systemic Lupus Erythematosus: Evaluating Differences in the Enrolled Populations
Abstract Number: 1709

Randomized, Double-Blind Study Comparing Chs-0214 with Etanercept (Enbrel) in Patients with Psoriasis and Psoriatic Arthritis
Abstract Number: 2008

Rapamycin Elicits Rapid and Lasting Improvement of Disease Activity through Blocking Pro-Inflammatory T Cell Lineage Specification in Patients with Active SLE
Abstract Number: 1699

RAPID3 Near Remission Shows Good Agreement with Minimal Disease Activity Criteria in Psoriatic Arthritis
Abstract Number: 3123

Rare Mediterranean Fever (MEFV) Gene Polymorphisms Are Associated with Ankylosing Spondylitis in Turkish and Iranian Population
Abstract Number: 1242

Rate of Hospitalization for Heart Failure Is Lower in Patients with Controlled Gout Versus Uncontrolled Gout
Abstract Number: 118

Rates and Determinants of Persistent Patient-Physician Discordance in Global Assessment of Disease Activity in Latinos with Rheumatoid Arthritis in the United States
Abstract Number: 1868

Rates and Predictors of Physical Therapy and Occupational Therapy Utilization in Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study
Abstract Number: 931

Rates of Lipid Testing and Statin Prescriptions Among SLE and Diabetes Mellitus Patients in a Nationwide Medicaid Cohort
Abstract Number: 2398

Reaching the Masses: A Novel Approach to Pediatric Rheumatology Education Via Tele-Learning
Abstract Number: 2668

Real Time Sonoelastography in Primary Sjögren’s Syndrome Correlates with Morphological Ultrasonographic Features and Glandular Activity but Not with Glandular Fibrosis
Abstract Number: 2603

Real World Practice Based Clinical Study of Delayed-Release Prednisone Produces Comparable Results to a Controlled Clinical Trial: Morning Stiffness and Disease Measures in Moderate-Severe RA Patients Switched from Immediate-Release to Delayed Release-Prednisone
Abstract Number: 2595

Real World Results from a Post-Approval Safety Surveillance of Tofacitinib (Xeljanz): Over 3 Year Results from an Ongoing US-Based Rheumatoid Arthritis Registry
Abstract Number: 2484

Real World Treat to Target Strategy in Rheumatoid Arthritis: Radiograph and MRI Outcomes in Three Cohorts with 18 Month Follow up
Abstract Number: 599

Real World United States-Based Clinical Experience with Prior Biologic Use Among First Time Golimumab Intravenous and Infliximab Treated Rheumatoid Arthritis Patients
Abstract Number: 2318

Real World Use of the Myositis Autoantibody Panel
Abstract Number: 2247

REAL-Life Cost of UK Healthcare Resource for Patients with Rheumatoid Arthritis, Comparing High and Low/Remission Disease States
Abstract Number: 2228

Real-World Cost of Treating Inadequate Responders to Anti-Tumor Necrosis Factor Therapy
Abstract Number: 1637

Real-World Use of Tofacitinib in Rheumatoid Arthritis: Data from the Swiss Clinical Quality Management RA Registry
Abstract Number: 2523

Reasons for Provider Non-Adherence to a Treat to Target Strategy in Rheumatoid Arthritis
Abstract Number: 2335

Recent Changes of Radiological Findings and Patients’ Background of Rheumatoid Hip and Knee
Abstract Number: 1987

Recessive Coding and Regulatory Mutations in FBLIM1 Underlie the Pathogenesis of Sterile Osteomyelitis
Abstract Number: 2221

Recognition of Secondary Fibromyalgia Using an Index of 3 Components of the Multi-Dimensional Health Assessment Questionnaire: 90% Agreement with ACR Criteria for Fibromyalgia
Abstract Number: 3071

Recombinant Human Proteoglycan-4 (rhPRG4) Inhibits Monosodium Urate (MSU) Crystal Phagocytosis By Human Macrophages and Resultant Inflammatory Response
Abstract Number: 2510

Recommendations for the Use of Parenteral Methotrexate in Rheumatic Diseases
Abstract Number: 3115

Reconsidering the Juvenile Idiopathic Arthritis Core Set: How Patients and Caregivers Define Disease Activity
Abstract Number: 2148

Recruitment of Circulating Monocytes By TNF/IL-6-Induced Expression of Vascular Cell Adhesion Molecule 1 (VCAM-1) Drives Valvular Inflammation in K/B/g7 Mice
Abstract Number: 1068

Recurrence of Thrombosis Despite Negativization of Antiphospholipid Antibodies in Primary Antiphospholipid Syndrome. a Follow-up to 5 Years
Abstract Number: 2881

Reduced Hippocampal-Thalamic Fiber Tracts in Systemic Lupus Erythematosus
Abstract Number: 2452

Reduced Ovarian Reserve in Young Juvenile Idiopathic Arthritis Patients
Abstract Number: 1146

Reducing Imaging Tests for Low Back Pain: Can Patients Choose Wisely?
Abstract Number: 2542

Reducing the Dosage of Glucocorticoid to Zero Might Decrease Risk of Clinical Fractures in Patients with Rheumatoid Arthritis: Five-Year Findings of the Tomorrow Study
Abstract Number: 145

Reduction in Musculoskeletal Ultrasound (MSK-US) Payments in 2014: Effects & Consequences
Abstract Number: 641

Reduction of Concomitant Oral Methotrexate or Corticosteroids in Combination Treatment with Adalimumab Does Not Affect Effectiveness in Patients with Rheumatoid Arthritis
Abstract Number: 1395

Regional Brain Gray Matter Volume Loss in Children and Adolescents with SLE
Abstract Number: 105

Regional Primary Care Rheumatology Networks for Patients with Rheumatic and Musculoskeletal Diseases: Need for a National Approach
Abstract Number: 2735

Regional Variability of Minimal Disease Activity Among Psoriatic Arthritis Patients in Canada: An Analysis from a Prospective, Observational Registry
Abstract Number: 2937

Regulation of Follicular Helper T (TFH) Cells By ROCK2 (Rho-associated coiled-coil containing protein kinase 2)
Abstract Number: 2698

Regulation of Inflammation By Interleukin-27 in a Rat Model of Spondyloarthritis (SpA)
Abstract Number: 664

Regulation of Interferon Signaling By a Calcium-Induced miRNA in Primary Human Salivary Gland Epithelial Cells
Abstract Number: 2106

Regulation of Marginal Zone B Cell Differentiation By microRNA-146a
Abstract Number: 2257

Regulation of Mitochondrial Proton Gradient Is Critical for NLRP3 Inflammasome Activation
Abstract Number: 1131

Regulation of Rheumatoid Arthritis Synovial Fibroblast Cytokine Production By Inhibitor of DNA Binding-1 Via Crispr/Cas9 Transfection
Abstract Number: 1450

Regulatory Mechanisms of Mesenchymal Stem Cell Transplantation on Systemic Osteoporosis in Collagen-Induced Arthritis Mice
Abstract Number: 1658

Regulatory Role of the IL-9/IL-9R System on Pannus Formation in Psoriatic Arthritis
Abstract Number: 3109

Regulatory T Cells Deficient in Protein Phosphatase 2A Lose Suppressive Function and Convert to an Effector Phenotype
Abstract Number: 1927

Relapses in Patients with ANCA-Associated Vasculitis: A Retrospective Study on Severity and Organ Involvement Compared to Initial Onset
Abstract Number: 2340

Relation Between Range of Motion and Physical Activity While Recovering after Total Knee Replacement
Abstract Number: 291

Relation of Foot Pronation during Walking to Risk of Worsening Lateral Patellofemoral and Medial Tibiofemoral Cartilage Damage
Abstract Number: 1980

Relation of Pain Sensitization to the Evolution from Intermittent to Chronic, Persistent Pain in Knee Osteoarthritis: The Multicenter Osteoarthritis Study
Abstract Number: 2345

Relation of Varus Knee Thrust during Walking to Two-Year Incidence of Frequent Ankle, Hip, and Lower Back Pain
Abstract Number: 2943

Relationship Between Menstruation and Symptoms of Behcet’s Syndrome
Abstract Number: 370

Relationship Between Alcohol Consumption and Symptom Severity in Chronic Pain Patients
Abstract Number: 758

Relationship Between Corticosteroids and Adverse Events in SLE –Data from the Clinical Trial Belimumab in Subjects with Systemic Lupus Erythematosus
Abstract Number: 689

Relationship Between Infliximab Serum Concentrations and Risk of Infections in Patients Treated for Spondyloarthritis
Abstract Number: 1572

Relationship Between KDR (VEGFR2) Gene Polymorphisms and Serum KDR Protein Levels in Patients with Rheumatoid Arthritis
Abstract Number: 229

Relationship Between Patient and Disease Factors and Severity of Gout in a Real-World Population
Abstract Number: 140

Relationship Between the Prevalence of Subclinical Tenosynovitis and Therapy in Patients with RA in Clinical Remission: Results from Italian Society of Rheumatology Study Group
Abstract Number: 2028

Relationship of Limb Length Inequality and Incident and Progressive Knee and Hip Radiographic Osteoarthritis and Symptoms
Abstract Number: 3105

Relationships Between a Serum Biomarker of B Cell Differentiation and B Cell Activating Factor Suggest Possible Distinct Pathways of Response to Rituximab in Patients with Systemic Lupus Erythematosus
Abstract Number: 1333

Relevance of Granulomatous Presentation for the Diagnosis and Outcome of Uveitis: Retrospective Case-Control Study of 251 Patients
Abstract Number: 2741

Reliability and Construct Validity of the Psoriatic Arthritis Impact of Disease (PsAID) Questionnaire – Independent Validation Study in a UK Cohort
Abstract Number: 971

Reliability and Minimal Clinically Important Differences (MCID) of Forced Vital Capacity: Post-Hoc Analyses from the Scleroderma Lung Studies (SLS-I and II)
Abstract Number: 936

Reliability and Responsiveness of an Omeract Tenosynovitis Magnetic Resonance Imaging Scoring System for the Rheumatoid Arthritis Wrist and Hand
Abstract Number: 1261

Reliability and Validity of the Patient Health Questionnaire-9 for Assessment of Depression in Socioeconomically Disadvantaged Latinos with Rheumatoid Arthritis Living in the United States
Abstract Number: 139

Reliability of Ultrasound in Detecting Cartilage Change in Patients with Rheumatoid Arthritis: A Study By Omeract Ultrasound Task Force
Abstract Number: 1888

Reliability, Validity, and Sensitivity to Change of the Simplified Duruoz Hand Index in Systemic Sclerosis
Abstract Number: 2466

Remission According to RAPID3 (routine assessment of patient index data 3) in Patients with Rheumatoid Arthritis: A Cross-Sectional 3 Center Study from Routine Care
Abstract Number: 1779

Remission and Low Lupus Disease Activity Status (LLDAS) Protect Lupus Patients from Damage Occurrence: Data from a Multi-Ethnic, Multinational Latin American Lupus Cohort
Abstract Number: 3147

Remote Inflammation Triggers Autoimmune Arthritis through Th17 Distribution
Abstract Number: 966

Renal Activity in Lupus (RAIL) Urinary Biomarkers Predict Treatment Response
Abstract Number: 206

Renal Safety of Lesinurad: A Pooled Analysis of Phase III and Extension Studies
Abstract Number: 443

Repetitive Requisition of Antinuclear Antibody Testing (ANA) in Outpatient Multispecialty Clinics in Patients with a Known Positive ANA
Abstract Number: 120

Reproductive Tract Infections (RTI) in Indian (Asian) Women of Child Bearing Age Suffering from RA:I Don’t Ask Them, They Don’t Tell Me
Abstract Number: 459

Resident Non-Classical Monocytes Are Critically Important for Tissue Destruction in Arthritis
Abstract Number: 2659

Respiratory Symptoms in Patients with Primary SjöGren’s Syndrome – a Case-Control Study
Abstract Number: 1358

Response of Hidradenitis Suppurativa to Biologic Therapy
Abstract Number: 769

Response to Belimumab in SLE Patients with High Disease Activity: Data from a Multicentric Clinical-Practice Based Study Cohort
Abstract Number: 2387

Response to Pamidronate Treatment Assessed By Whole Body Magnetic Resonance Imaging in Pediatric Chronic Non-Bacterial Osteomyelitis
Abstract Number: 3237

Responsiveness and Its Magnitude in the 36-Item Short Form Health Survey and the Lupus Quality of Life Questionnaire in Patients with Active Disease
Abstract Number: 1421

Responsiveness of Lupus Impact Tracker Among Chinese Patients with Lupus
Abstract Number: 2040

Responsiveness of Patient Reported Outcomes Measurement Information System Measures in RA Patients Starting or Switching a DMARD
Abstract Number: 188

Responsiveness to X-Linked Toll-like Receptors Differs Between Mice with XY and XX Sex Chromosome Complement, Regardless of the Gonadal Sex
Abstract Number: 2569

Restoration of Decreased Lymphocyte Counts and the Shift to Th1 and Effector Memory CD8+T Cell Subsets Associate with Spontaneous Regression of Lympho-Proliferative Disorders Developed in RA Patients Treated with Methotrexate
Abstract Number: 2857

Results from a Phase 0 Longitudinal Clinical Trial in Cutaneous Lupus Erythematosus: Analysis of the Type I IFN Signature in the Skin and Blood and Its Relationship with Disease Activity Scores and Autoantibody Profiles
Abstract Number: 2653

Results of a Comprehensive Review of Pulmonary Function and Safety Data in a Phase IIb Clinical Program Testing Anti-GM-CSF Receptor Antagonist Mavrilimumab for Treatment of RA
Abstract Number: 321

Results of a Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Romosozumab in Men with Osteoporosis
Abstract Number: 2483

Results of a Pilot Study of a Tailored Symptom Assessment Tool to Enhance Patient-Centered Care in Rheumatoid Arthritis: Choice RA
Abstract Number: 2656

Resume of Biologic Therapy after Tuberculosis Infection in Patients with Inflammatory Arthropathies. Daily Clinical Practice Data from an Endemic Country
Abstract Number: 2628

Retention of Use and Safety of Subcutaneous Abatacept in Rheumatoid Arthritis: A Patient Record Assessment in a Compassionate Use Programme in South Africa, a Tuberculosis Endemic Country
Abstract Number: 3031

Rethinking Primary Sjögren’s Syndrome: Stratification By Clinical Phenotypes to Improve Understanding of Disease Pathogenesis, Trial Design, Clinical Management and Prospective Health Gains?
Abstract Number: 929

Retinal Examinations Among SLE Patients Newly-Initiating Hydroxychloroquine in a U.S. Medicaid SLE Population, 2000-10
Abstract Number: 1191

Retinal Vessel Morphometry Associations with Polymyalgia Rheumatica; Findings from the European Prospective Investigation of Cancer (EPIC) in Norfolk
Abstract Number: 923

Retinoic Acid Inhibits Expression of Interleukin 9 By Altering Enhancer Architecture
Abstract Number: 270

Retinoic Acid-Inducible Gene-I Increased in Peripheral CD3+T Lymphocytes of Patients with Dermatomyositis
Abstract Number: 2620

Retrospective Analysis for Determining the Signs and Symptoms of Infections before They Become Serious in Tocilizumab-Treated RA Patients Using a Postmarketing Adverse Events Reporting Database
Abstract Number: 1941

Retrospective Survey of Concomitant Autoimmune Diseases and Autoantibodies in a Cohort of Patients with ANCA-Associated Vasculitis (AAV)
Abstract Number: 783

Review of SLE Cohort to Identify Predictors of Response to B Cell Depletion in Patients with Active SLE
Abstract Number: 1138

Rheumapalooza Update: Applying a Flipped Classroom Instructional Model to an Intensive Rheumatology Curriculum for Second Year Medical Students
Abstract Number: 1341

Rheumatic and Musculoskeletal Immune-Related Adverse Events Due to Immune Checkpoint Inhibitors: A Systematic Literature Review
Abstract Number: 1339

Rheumatic Immune Related Adverse Events of Checkpoint Therapy for Cancer: Case Series of a New Nosologic Entity
Abstract Number: 2

Rheumatoid Arthritis (RA)-Related Autoimmunity and Lumbar Bone Mineral Density in a Multi-Ethnic Community-Dwelling Population
Abstract Number: 4

Rheumatoid Arthritis (RA)-Related Joint Symptoms and Thoracic Bone Mineral Density in an RA-Free Community Dwelling Population
Abstract Number: 3152

Rheumatoid Arthritis (RA): Premature Use of Biologics Accelerating in United States (US)
Abstract Number: 2652

Rheumatoid Arthritis and Excess Mortality Associated with Treatments: a Systematic Review and Meta-Analysis
Abstract Number: 1549

Rheumatoid Arthritis and Periodontal Disease: Salivary ACPA Levels and Clinical Presentation
Abstract Number: 5

Rheumatoid Arthritis and Periodontitis: Association and Characteristics of Chronic Periodontitis
Abstract Number: 1917

Rheumatoid Arthritis Cells Produce Extracellular Vesicles That Incorporate PD-1 and microRNAs Targeting the PD-1 Pathway in Surrounding Cells
Abstract Number: 2441

Rheumatoid Arthritis Flares and Pregnancy Outcomes Among Women in a Longitudinal Registry
Abstract Number: 1992

Rheumatoid Arthritis Is an Independent Risk Factor for Increased Insulin Resistance and Impaired Beta-Cell Function: Impact of Disease Activity
Abstract Number: 1551

Rheumatoid Arthritis Is Associated with Low-/Mid-Frequency Hearing Impairment: Data from the Korean National Health and Nutrition Examination Survey
Abstract Number: 566

Rheumatoid Arthritis Patients’ Ability to Accurately Recall DMARD Information Immediately Following an Office Visit with Their Rheumatologist
Abstract Number: 1236

Rheumatoid Arthritis-Interstitial Lung Disease in the United States: Prevalence, Incidence, and Healthcare Costs
Abstract Number: 26

Rheumatoid Factor Positivity Increases All-Cause and Cancer Mortality Risk in Korean Healthy Examinees: A Kangbuk Samsung Health Study
Abstract Number: 2115

Rheumatoid Factors May Potentiate Immune Complex Formation of Anti-Citrullinated Protein Antibodies
Abstract Number: 3080

Rheumatologic Consequences of Immunotherapy to Treat Malignancies: The Tip of an Iceberg
Abstract Number: 1313

Rheumatologic Diseases in HIV-Infected Patients in the Post-Antiretroviral Therapy Era: The County Experience
Abstract Number: 1418

Rheumatologist: If You Fell Ill with Seropositive Active Rheumatoid Arthritis Yourself, What to Do!
Abstract Number: 101

Rheumatology Care Utilization and Geographic Distance from Rheumatology Sites within the United States Veteran Affairs Health Care System
Abstract Number: 1149

Rheumatology Elective Time in a 4+1 Residency Structure: Evaluating Impact of a Novel Residency Schedule Structure on Rheumatology Resident Education
Abstract Number: 856

Rho Kinase Ezpression in Giant Cell Arteritis: Validating Perm Intensity Score As a Method of Increasing Sensitivity of Temporal Artery Biopsy
Abstract Number: 1886

Right Ventricular Load-Adaptability and Response to Therapy in Scleroderma Versus Idiopathic Pulmonary Arterial Hypertension
Abstract Number: 1020

Risk Factors Can Classify Individuals Who Develop Accelerated Knee Osteoarthritis
Abstract Number: 2456

Risk Factors for Adverse Pregnancy Outcome in Antiphospholipid Antibodies Carriers: Results from a Multicenter Italian Cohort over 20 Years of Experience
Abstract Number: 2051

Risk Factors for Cardiovascular Disease Predate the Onset of Symptoms of Rheumatoid Arthritis
Abstract Number: 1773

Risk Factors for Cerebrovascular Events in Systemic Lupus Erythematosus: Results from an International, Inception Cohort Study
Abstract Number: 1181

Risk Factors for Incident Fractures in Patients with Systemic Lupus Erythematosus on Dialysis
Abstract Number: 1798

Risk Factors for Osteonecrosis in Systemic Lupus Erythematosus: A Systematic Review
Abstract Number: 773

Risk Factors for Severe Infections in Rituximab Treated Patients: Comparison of Systemic Lupus Erythematosus and Inflammatory Myositis
Abstract Number: 2643

Risk Factors of Pneumocystis Jiroveci Pneumonia (PJP) in Patients with RA and Sulfasalazine As a Possible Protective Agent
Abstract Number: 1353

Risk Factors of Pulmonary Mycobacterium Avium-Comlex (MAC) Disease and the Significance of Anti-MAC Antibody in Patients with Rheumatic Diseases
Abstract Number: 2618

Risk Factors of Severe Infections in Patients with Rheumatoid Arthritis Treated with Tocilizumab in the French Registry Regate (REGISTRY –ROACTEMRA)
Abstract Number: 683

Risk Factors of Uveitis in Ankylosing Spondylitis
Abstract Number: 896

Risk for Cardiovascular Disease in Giant Cell Arteritis and Polymyalgia Rheumatica
Abstract Number: 1496

Risk for Serious Infection in Rheumatoid Arthritis Associated Interstitial Lung Disease
Abstract Number: 1714

Risk of 10-Year Cardiovascular Disease Assessed By Framingham Risk Score Is Similar in Patients with Psoriatic Arthritis and Psoriasis As Assessed By Atherosclerotic Cardiovascular Disease and Framingham Risk Scores
Abstract Number: 260

Risk of Cardiovascular Disease Among Patients with Sarcoidosis: A Population-Based Retrospective Cohort Study
Abstract Number: 2989

Risk of Cardiovascular Disease Events Among Patients with Systemic Lupus Erythematosus Compared to Those with Diabetes Mellitus in a Nationwide Medicaid Cohort
Abstract Number: 877

Risk of Coronary Artery Disease in Patients with Polymyalgia Rheumatica: A Systematic Review and Meta-Analysis
Abstract Number: 2646

Risk of Hepatitis B Reactivation in Inflammatory Arthritis Patients Receiving Disease Modifying Anti-Rheumatic Drugs (DMARDs): A Systematic Review and Meta-Analysis
Abstract Number: 1195

Risk of Hospitalized Infection Among Patients with Sarcoidosis: A Population-Based Retrospective Cohort Study
Abstract Number: 3066

Risk of Incident Cancer with Biologic and Tofacitinib Therapy in Rheumatoid Arthritis
Abstract Number: 1991

Risk of Incident Diabetes Mellitus and Its Association with Disease-Modifying Antirheumatic Drugs and Statins in Rheumatoid Arthritis
Abstract Number: 3116

Risk of Infections in Juvenile Idiopathic Arthritis Patients Treated with Biologic Agentsand/or Methotrexate: Results from Pharmachild Registry
Abstract Number: 2029

Risk of Knee Pain, Radiographic Osteoarthritis and Knee Arthroplasty in Retired Professional Footballers Compared to the General Population
Abstract Number: 2813

Risk of Renal Failure within 10 or 20 Years of SLE Diagnosis, By Patient Characteristics
Abstract Number: 988

Risk of Rheumatoid Arthritis after Transfusion of Blood from Donors Later Diagnosed with Rheumatoid Arthritis: A Retrospective Cohort Study
Abstract Number: 29

Risk of Vascular Mortality in Seniors with New-Onset Rheumatoid Arthritis
Abstract Number: 2939

Risk of Venous Thromboembolism in Patients with Systemic Vasculitides: A Systematic Review and Meta-Analysis
Abstract Number: 763

Rituximab As a Corticosteroid-Sparing Agent in Patients with Systemic Lupus Erythematosus
Abstract Number: 907

Rituximab in Patients with Takayasu Arteritis: A Single Center Experience on Five Patients
Abstract Number: 259

Rituximab in Refractory Cardiac Sarcoidosis – Single Center Experience
Abstract Number: 2904

Rituximab in Systemic Sclerosis-Interstitial Lung Disease, a Case Series of 18 Patients
Abstract Number: 387

Rituximab Should be Considered in Rheumatoid Factor Negative Poly-Articular Juvenile Idiopathic Arthritis
Abstract Number: 2118

Rituximab Treated Non Responder Rheumatoid Arthritis Patients Are Generating a New Autoantibody Repertoire
Abstract Number: 2088

Rituximab Use in Pediatric Lupus Anticoagulant Hypoprothrombinemia Syndrome – Report of Three Cases and Review of the Literature
Abstract Number: 1955

Rituximab Versus Azathioprine to Maintain Remission of ANCA-Associated Vasculitides (MAINRITSAN): Follow-up at 60 Months
Abstract Number: 817

RNA and Protein Cargo of Exosomes Isolated from Serum of Systemic Sclerosis Patients Induce a Profibrotic Phenotype in Cultured Normal Human Dermal Fibroblasts: A Potential Mechanism for the Initiation and Progression of a Profibrotic Phenotype in SSc
Abstract Number: 669

RNA-Sequencing Reveals Sjogren’s Syndrome Anti-Ro Negative Patients Share Similar Pathways to Multiple Sclerosis Patients
Abstract Number: 2418

Rnaseq Reveals Treatment-Associated Gene Expression Dynamics in Juvenile Idiopathic Arthritis CD4+ T Cells
Abstract Number: 2457

Role of Hydroxychloroquine in Improving Pregnancy Outcomes in Women with Antiphospholipid Antibodies without Other Underlying Connective Tissue Disease
Abstract Number: 1660

Role of Immune System Cells and Induction of Netosis-Mediated Cell Death in the Development of Atherosclerosis in Ankylosing Spondylitis
Abstract Number: 469

Role of Microbiota in Development of Autoimmune Arthritis
Abstract Number: 2258

Role of NLRP12 on Disease Severity in Autoimmune Arthritis
Abstract Number: 2386

Role of Pentraxin 3 in Patients with Juvenile Scleroderma
Abstract Number: 2808

Role of Serum Autoantibodies in Blood Brain Barrier Damages in Neuropsychiatric Systemic Lupus Erythematosus
Abstract Number: 222

Role of Synovial Biopsy in Diagnosis of Crystal Arthropathies
Abstract Number: 3144

Role of the Gut Microbiome in Modulating Arthritis Progression in Mice
Abstract Number: 2926

Rorc Positive Th17, Th17/Th1, and Th17.1 Cells from the Blood of Treatment NaïVe RA Patients Differ in IL-17A but Are All Pathogenic When Co-Cultured with RA Synovial Fibroblasts